The first blood test to detect the presence of amyloid, a hallmark of Alzheimer's disease (AD), is now available for clinical use, the company behind the test's development, C2N Diagnostics, has announced. The availability of the noninvasive, easily administered test is being called a milestone in the early detection and diagnosis of AD.
Neutrophil granulocyte biomarkers can distinguish between neuromyelitis optica spectrum disorders (NMOSD) and anti-MOG antibody-associated disease (MOGAD) on one hand and multiple sclerosis (MS) on the other hand.
In a new article ( Murueta‐Goyena, A., Del Pino, R., Galdós, et al. (2020), Retinal thickness predicts the risk of cognitive decline in Parkinson's disease. Ann Neurol doi:10.1002/ana.25944) the researchers analyzed longitudinal changes of retinal thickness and their predictive value as biomarkers of disease progression in idiopathic Parkinson's...
A new study has added support to the idea that coffee consumption is associated with a reduced risk of developing Parkinson's disease and suggests that caffeine may be a particularly beneficial for individuals with a genetic mutation linked to the condition.
Atogepant is an orally administered, small-molecule, calcitonin gene-related peptide (CGRP) receptor antagonist under investigation for treatment of migraine.
Listening to Mozart's piano music improves epilepsy, according to a meta-analysis presented at the virtual congress of the European College of Neuropsychopharmacology.
In patients with pediatric-onset multiple sclerosis (MS), increased abundance of Blautia stercoris and its variants in the gut is associated with an increased risk of relapse.
Rapid eye movement (REM) sleep has been linked with health outcomes, but little is known about the relationship between REM sleep and mortality.
Indicators of early-life cognitive enrichment (ELCE) have been associated with slower cognitive decline and decreased dementia in late life.
This recent retrospective cohort study included the review of medical records of patients with isolated or recurrent transient global amnesia (TGA) who presented at the Mayo Clinic in Rochester, Minnesota, between August 1, 1992 and February 28, 2018. A total of 1491 cases were examined and 1044 met the diagnostic inclusion criteria for TGA, while...
